Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2023-11-07 Sale | 2023-11-08 4:22 pm | NovoCure Ltd | NVCR | Shah Pritesh Chief Growth Officer | 382 | $12.65 | $4,832 | 124,511 (Direct) | View |
| 2023-09-01 Sale | 2023-09-05 4:23 pm | NovoCure Ltd | NVCR | Shah Pritesh Chief Growth Officer | 273 | $21.82 | $5,956 | 124,893 (Direct) | View |
| 2023-03-03 Sale | 2023-03-07 4:52 pm | NovoCure Ltd | NVCR | Shah Pritesh Chief Growth Officer | 21,421 | $76.16 | $1,631,411 | 124,799 (Direct) | View |
| 2023-03-02 Sale | 2023-03-06 4:41 pm | NovoCure Ltd | NVCR | Shah Pritesh Chief Growth Officer | 937 | $75.28 | $70,535 | 146,220 (Direct) | View |
| 2023-03-01 Sale | 2023-03-02 5:00 pm | NovoCure Ltd | NVCR | Shah Pritesh Chief Growth Officer | 1,923 | $76.36 | $146,845 | 131,666 (Direct) | View |
| 2023-01-05 Sale | 2023-01-09 6:20 pm | NovoCure Ltd | NVCR | Shah Pritesh Chief Commercial Officer | 387 | $108 | $41,796 | 82,843 (Direct) | View |
| 2022-09-02 Sale | 2022-09-06 5:12 pm | NovoCure Ltd | NVCR | Shah Pritesh Chief Commercial Officer | 269 | $79.04 | $21,261 | 83,230 (Direct) | View |
| 2022-03-09 Sale | 2022-03-11 4:54 pm | NovoCure Ltd | NVCR | Shah Pritesh Chief Commercial Officer | 3,669 | $71.19 | $261,196 | 86,904 (Direct) | View |
| 2022-03-07 Sale | 2022-03-09 4:56 pm | NovoCure Ltd | NVCR | Shah Pritesh Chief Commercial Officer | 7,775 | $69.73 | $542,116 | 81,908 (Direct) | View |
| 2022-03-03 Sale | 2022-03-07 6:23 pm | NovoCure Ltd | NVCR | Shah Pritesh Chief Commercial Officer | 5,543 | $72.54 | $402,064 | 133,941 (Direct) | View |
| 2021-09-02 Sale | 2021-09-07 4:32 pm | NovoCure Ltd | NVCR | Shah Pritesh Chief Commercial Officer | 657 | $138.57 | $91,041 | 73,512 (Direct) | View |
| 2021-08-04 Sale | 2021-08-06 4:41 pm | NovoCure Ltd | NVCR | Shah Pritesh Chief Commercial Officer | 2,063 | $148.71 | $306,789 | 74,169 (Direct) | View |
| 2021-08-03 Sale | 2021-08-04 5:09 pm | NovoCure Ltd | NVCR | Shah Pritesh Chief Commercial Officer | 1,654 | $149.43 | $247,157 | 76,232 (Direct) | View |
| 2021-06-10 Sale | 2021-06-11 4:26 pm | NovoCure Ltd | NVCR | Shah Pritesh Chief Commercial Officer | 23,540 | $215 | $5,061,100 | 77,732 (Direct) | View |
| 2021-05-05 Sale | 2021-05-06 4:17 pm | NovoCure Ltd | NVCR | Shah Pritesh Chief Commercial Officer | 1,290 | $199.67 | $257,574 | 101,272 (Direct) | View |
| 2021-05-04 Sale | 2021-05-05 4:09 pm | NovoCure Ltd | NVCR | Shah Pritesh Chief Commercial Officer | 1,043 | $200.86 | $209,493 | 102,562 (Direct) | View |
| 2021-03-05 Sale | 2021-03-09 4:17 pm | NovoCure Ltd | NVCR | Shah Pritesh Chief Commercial Officer | 4,550 | $131.53 | $598,462 | 107,423 (Direct) | View |
| 2020-09-09 Sale | 2020-09-11 4:19 pm | NovoCure Ltd | NVCR | Shah Pritesh Chief Commercial Officer | 28,321 | $85.41 | $2,418,881 | 70,465 (Direct) | View |
| 2020-09-02 Sale(A) | 2020-09-11 4:13 pm | NovoCure Ltd | NVCR | Shah Pritesh Chief Commercial Officer | 4,200 | $85.01 | $357,054 | 98,786 (Direct) | View |
| 2020-09-02 Purchase | 2020-09-03 4:37 pm | NovoCure Ltd | NVCR | Shah Pritesh Chief Commercial Officer | 4,200 | $85.01 | $357,054 | 102,565 (Direct) | View |
| 2020-08-03 Sale | 2020-08-05 4:13 pm | NovoCure Ltd | NVCR | Shah Pritesh Chief Commercial Officer | 3,717 | $76.63 | $284,828 | 101,018 (Direct) | View |
| 2020-05-05 Sale | 2020-05-07 4:48 pm | NovoCure Ltd | NVCR | Shah Pritesh Chief Commercial Officer | 1,149 | $62.2 | $71,468 | 100,693 (Direct) | View |
| 2020-05-04 Sale | 2020-05-05 4:32 pm | NovoCure Ltd | NVCR | Shah Pritesh Chief Commercial Officer | 1,184 | $60.08 | $71,134 | 104,175 (Direct) | View |
| 2020-03-02 Sale | 2020-03-05 4:47 pm | NovoCure Ltd | NVCR | Shah Pritesh Chief Commercial Officer | 1,485 | $72.97 | $108,360 | 67,721 (Direct) | View |
| 2020-02-28 Sale | 2020-03-02 5:22 pm | NovoCure Ltd | NVCR | Shah Pritesh Chief Commercial Officer | 1,601 | $72.22 | $115,616 | 72,292 (Direct) | View |
| 2020-02-25 Sale | 2020-02-28 4:41 pm | NovoCure Ltd | NVCR | Shah Pritesh Chief Commercial Officer | 12,999 | $80.08 | $1,040,943 | 67,721 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2023-06-30 Option Award | 2023-07-06 4:14 pm | N/A N/A | NovoCure Ltd | NVCR | Shah Pritesh Chief Growth Officer | 367 | $35.28 | 125,166 (Direct) | View |
| 2023-03-03 Option Award | 2023-03-06 4:41 pm | N/A N/A | NovoCure Ltd | NVCR | Shah Pritesh Chief Growth Officer | 47,182 | $0 | 146,220 (Direct) | View |
| 2023-02-28 Option Award | 2023-03-02 5:00 pm | N/A N/A | NovoCure Ltd | NVCR | Shah Pritesh Chief Growth Officer | 19,055 | $0 | 131,666 (Direct) | View |
| 2023-02-28 Option Award | 2023-03-02 5:00 pm | 2024-02-28 2033-02-27 | NovoCure Ltd | NVCR | Shah Pritesh Chief Growth Officer | 31,691 | $76.97 | 131,666 (Direct) | View |
| 2022-07-05 Option Award | 2022-07-07 5:45 pm | N/A N/A | NovoCure Ltd | NVCR | Shah Pritesh Chief Commercial Officer | 312 | $59.08 | 83,499 (Direct) | View |
| 2021-07-31 Exercise | 2022-03-11 4:54 pm | 2021-07-31 N/A | NovoCure Ltd | NVCR | Shah Pritesh Chief Commercial Officer | 3,717 | $0 | 86,904 (Direct) | View |
| 2021-07-31 Exercise | 2022-03-11 4:54 pm | N/A N/A | NovoCure Ltd | NVCR | Shah Pritesh Chief Commercial Officer | 3,717 | $154.01 | 86,904 (Direct) | View |
| 2022-03-03 Option Award | 2022-03-07 6:23 pm | N/A N/A | NovoCure Ltd | NVCR | Shah Pritesh Chief Commercial Officer | 21,714 | $0 | 133,941 (Direct) | View |
| 2022-03-03 Option Award | 2022-03-07 6:23 pm | 2023-03-01 2032-02-29 | NovoCure Ltd | NVCR | Shah Pritesh Chief Commercial Officer | 44,258 | $80.59 | 133,941 (Direct) | View |
| 2021-07-06 Option Award | 2021-07-08 5:29 pm | N/A N/A | NovoCure Ltd | NVCR | Shah Pritesh Chief Commercial Officer | 154 | $137.12 | 77,886 (Direct) | View |
| 2021-05-03 Exercise | 2021-05-05 4:09 pm | 2021-05-01 N/A | NovoCure Ltd | NVCR | Shah Pritesh Chief Commercial Officer | 2,333 | $0 | 102,562 (Direct) | View |
| 2021-05-03 Exercise | 2021-05-05 4:09 pm | N/A N/A | NovoCure Ltd | NVCR | Shah Pritesh Chief Commercial Officer | 2,333 | $204.1 | 102,562 (Direct) | View |
| 2021-03-05 Exercise | 2021-03-09 4:17 pm | N/A N/A | NovoCure Ltd | NVCR | Shah Pritesh Chief Commercial Officer | 13,987 | $7.15 | 107,423 (Direct) | View |
| 2021-03-05 Exercise | 2021-03-09 4:17 pm | N/A 2027-02-21 | NovoCure Ltd | NVCR | Shah Pritesh Chief Commercial Officer | 13,987 | $0 | 107,423 (Direct) | View |
| 2021-03-02 Option Award | 2021-03-04 5:46 pm | N/A 2031-03-01 | NovoCure Ltd | NVCR | Shah Pritesh Chief Commercial Officer | 30,890 | $0 | 122,822 (Direct) | View |
| 2021-02-27 Exercise | 2021-03-02 4:18 pm | 2021-02-27 N/A | NovoCure Ltd | NVCR | Shah Pritesh Chief Commercial Officer | 3,086 | $0 | 92,844 (Direct) | View |
| 2021-02-27 Exercise | 2021-03-02 4:18 pm | N/A N/A | NovoCure Ltd | NVCR | Shah Pritesh Chief Commercial Officer | 3,086 | $149.1 | 92,844 (Direct) | View |
| 2020-10-29 Exercise | 2020-10-30 4:08 pm | N/A N/A | NovoCure Ltd | NVCR | Shah Pritesh Chief Commercial Officer | 10,037 | $11.46 | 89,758 (Direct) | View |
| 2020-10-29 Exercise | 2020-10-30 4:08 pm | N/A 2024-02-25 | NovoCure Ltd | NVCR | Shah Pritesh Chief Commercial Officer | 30,468 | $0 | 89,758 (Direct) | View |
| 2020-10-29 Exercise | 2020-10-30 4:08 pm | N/A N/A | NovoCure Ltd | NVCR | Shah Pritesh Chief Commercial Officer | 14,518 | $7.48 | 89,758 (Direct) | View |
| 2020-10-29 Exercise | 2020-10-30 4:08 pm | N/A N/A | NovoCure Ltd | NVCR | Shah Pritesh Chief Commercial Officer | 5,913 | $14.37 | 89,758 (Direct) | View |
| 2020-09-01 Option Award | 2020-09-03 4:37 pm | N/A 2030-08-31 | NovoCure Ltd | NVCR | Shah Pritesh Chief Commercial Officer | 5,747 | $0 | 102,565 (Direct) | View |
| 2020-07-31 Exercise | 2020-08-03 5:39 pm | 2020-07-31 N/A | NovoCure Ltd | NVCR | Shah Pritesh Chief Commercial Officer | 3,717 | $0 | 108,452 (Direct) | View |
| 2020-07-31 Exercise | 2020-08-03 5:39 pm | N/A N/A | NovoCure Ltd | NVCR | Shah Pritesh Chief Commercial Officer | 3,717 | $76.17 | 108,452 (Direct) | View |
| 2020-07-07 Option Award | 2020-07-08 4:25 pm | N/A N/A | NovoCure Ltd | NVCR | Shah Pritesh Chief Commercial Officer | 325 | $50.41 | 101,018 (Direct) | View |
| 2020-05-01 Exercise | 2020-05-05 4:32 pm | 2019-05-01 N/A | NovoCure Ltd | NVCR | Shah Pritesh Chief Commercial Officer | 2,333 | $0 | 104,175 (Direct) | View |
| 2020-05-01 Exercise | 2020-05-05 4:32 pm | N/A N/A | NovoCure Ltd | NVCR | Shah Pritesh Chief Commercial Officer | 2,333 | $65.8 | 104,175 (Direct) | View |
| 2020-03-06 Exercise | 2020-03-10 4:20 pm | N/A 2024-02-25 | NovoCure Ltd | NVCR | Shah Pritesh Chief Commercial Officer | 17,500 | $7.48 | 115,211 (Direct) | View |
| 2020-03-03 Option Award | 2020-03-05 6:58 pm | N/A 2030-03-02 | NovoCure Ltd | NVCR | Shah Pritesh Chief Commercial Officer | 63,313 | $0 | 131,034 (Direct) | View |
| 2020-02-27 Exercise | 2020-03-02 5:22 pm | 2019-02-27 N/A | NovoCure Ltd | NVCR | Shah Pritesh Chief Commercial Officer | 3,086 | $0 | 72,292 (Direct) | View |
| 2020-02-27 Exercise | 2020-03-02 5:22 pm | N/A N/A | NovoCure Ltd | NVCR | Shah Pritesh Chief Commercial Officer | 3,086 | $79.45 | 72,292 (Direct) | View |
| 2020-02-24 Exercise | 2020-02-26 5:18 pm | 2020-02-22 N/A | NovoCure Ltd | NVCR | Shah Pritesh Chief Commercial Officer | 12,999 | $0 | 80,720 (Direct) | View |
| 2020-02-24 Exercise | 2020-02-26 5:18 pm | N/A N/A | NovoCure Ltd | NVCR | Shah Pritesh Chief Commercial Officer | 12,999 | $88.26 | 80,720 (Direct) | View |